News
![Owlstone's ReCIVA is being developed to diagnose lung cancer, but also has applications in precision medicine trials](https://pharmaphorum.com/wp-content/uploads/2016/11/ReCIVA-Owlstone.jpg)
CRUK and Owlstone launch trial for cancer breath test
Cancer Research UK and Owlstone Medical have launched a clinical trial to develop a breath test that could detect cancer at an early stage – the first test of its kind to investigate multip